MicroRNA‐483 amelioration of experimental pulmonary hypertension

Endothelial dysfunction is critically involved in the pathogenesis of pulmonary arterial hypertension (PAH) and that exogenously administered microRNA may be of therapeutic benefit. Lower levels of miR‐483 were found in serum from patients with idiopathic pulmonary arterial hypertension (IPAH), part...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jin, He, Yangyang, Yan, Xiaosong, Chen, Shanshan, He, Ming, Lei, Yuyang, Zhang, Jiao, Gongol, Brendan, Gu, Mingxia, Miao, Yifei, Bai, Liang, Cui, Xiaopei, Wang, Xiaojian, Zhang, Yixin, Fan, Fenling, Li, Zhao, Shen, Yuan, Chou, Chih‐Hung, Huang, Hsien‐Da, Malhotra, Atul, Rabinovitch, Marlene, Jing, Zhi‐Cheng, Shyy, John Y‐J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207157/
https://www.ncbi.nlm.nih.gov/pubmed/32324970
http://dx.doi.org/10.15252/emmm.201911303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207157/
https://www.ncbi.nlm.nih.gov/pubmed/32324970
http://dx.doi.org/10.15252/emmm.201911303

Ejemplares similares